IL17A and neoplasm: In agreement with these functions, our MPM AFs showed increased expression of IL-6, IL-17A, PDGFs, various FGFs and IGF-1 (Fig. 2A, B, D), all molecules reported to improve the survival and chemoresistance of tumour cells through their cross-talk with CAFs [28].